For in vitro diagnostic use. Others IGG-2 IVD IGG-2 CPS_000128 Tina-quant IgG Gen.2 08057915190 IGG-2, 300T, cobas c pack green IGG-2 07613336121320 Reagents, kits 300 tests cobas c 303/503/703 true 03507432190 IGG Gen.2, 150Tests, cobas c IGG-2 04015630919710 Reagents, kits 150 tests cobas c 311/501/502 true 05220718190 IGG Gen.2, 500Tests, cobas c701 IGG-2 04015630925735 Reagents, kits 500 tests cobas c 701/702 true 0408057915190c503CE0123 IGG-2 Tina-quant IgG Gen.2 CSF en 6 FF0000000689140E FF0000000492820E 08057915190 10299 cobas c 703 9493 cobas c 303 8481 cobas c 503 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of IgG specifically in human cerebrospinal fluid and corresponding human serum/plasma on cobas c systems. en 08057915500 IGG-2 Tina-quant IgG Gen.2 en 7 FF000000071E1A0E FF0000000492720E 08057915190 10299 cobas c 703 9493 cobas c 303 8481 cobas c 503 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of IgG in human serum, plasma, cerebrospinal fluid and urine on cobas c systems. Intended use of the specific applications for Reiber diagnostic**not available in all countriesIn vitro test for the quantitative determination of IgG specifically in human cerebrospinal fluid and corresponding human serum/plasma on cobas c system. en 0208057915190c503 IGG-2 Tina-quant IgG Gen.2 en 3 FF000000049C2C0E FF00000003F73C0E 08057915190 9493 cobas c 303 8481 cobas c 503 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use In vitro test for the quantitative determination of IgG in human serum, plasma and cerebrospinal fluid on Roche/Hitachi cobas c systems. en 0208057915190c503 IGG-2 Tina-quant IgG Gen.2 en 4 FF00000006A9D50E FF000000049C2C0E 08057915190 9493 cobas c 303 8481 cobas c 503 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use In vitro test for the quantitative determination of IgG in human serum, plasma and cerebrospinal fluid on Roche/Hitachi cobas c systems. en 0203507432190c501 IGG-2 Tina-quant IgG Gen.2 en 15 FF00000006AC8E0E FF000000008E960E 03507432190 308 cobas c 311 2324 cobas c 502 309 cobas c 501 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use In vitro test for the quantitative determination of IgG in human serum, plasma and cerebrospinal fluid on Roche/Hitachi cobas c systems. en 03507432500 IGG-2 Tina-quant IgG Gen.2 en 17 FF000000071E0B0E FF000000002EDA0E 03507432190 308 cobas c 311 2324 cobas c 502 309 cobas c 501 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of IgG in human serum, plasma, cerebrospinal fluid and urine on cobas c systems. Intended use of the specific applications for Reiber diagnostic**not available in all countriesIn vitro test for the quantitative determination of IgG specifically in humancerebrospinal fluid and corresponding human serum/plasma on cobas c system. en 0403507432190c501CE0123 IGG-2 Tina-quant IgG CSF en 5 FF000000068A230E FF0000000153CA0E 03507432190 2324 cobas c 502 309 cobas c 501 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of IgG specifically in human cerebrospinal fluid and corresponding human serum/plasma on Roche/Hitachi cobas c 501/502 systems. en 05220718500 IGG-2 Tina-quant IgG Gen.2 en 14 FF000000071E230E FF0000000028310E 05220718190 2492 cobas c 702 310 cobas c 701 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of IgG in human serum, plasma, cerebrospinal fluid and urine on cobas c systems. en 0205220718190c701 IGG-2 Tina-quant IgG Gen.2 en 9 FF00000006AC980E FF0000000092C70E 05220718190 2492 cobas c 702 310 cobas c 701 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use In vitro test for the quantitative determination of IgG in human serum, plasma, and cerebrospinal fluid on Roche/Hitachi cobas c systems. en